Rankings
▼
Calendar
AVBP Q3 2022 Earnings — ArriVent BioPharma, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
AVBP
ArriVent BioPharma, Inc. Common Stock
$1B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-0.35
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$113,000
← FY 2022
All Quarters
Q4 2022 →
